Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levomepromazine 25mg tablets
0402010K0AAAAAA
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 7,849 |
|
Levomepromazine 6mg tablets
0402010K0AAAMAM
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 965 |
|
Levomepromazine 6.25mg tablets
0402010K0AAAWAW
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 693 |
|
Levomepromazine 50mg tablets
0402010K0AAAVAV
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 204 |
|
Levomepromazine 6mg/5ml oral suspension
0402010K0AAAUAU
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 81 |
|
Levomepromazine 2.5mg/5ml oral suspension
0402010K0AAARAR
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 66 |
|
Levomepromazine 5mg/5ml oral liquid
0402010K0AAAGAG
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 17 |
|
Levomepromazine 62.5mg/5ml oral suspension
0402010K0AAASAS
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 1 |
|
Levomepromazine 10mg/5ml oral liquid
0402010K0AAAJAJ
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 12.5mg/5ml oral liquid
0402010K0AAAEAE
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 1mg capsules
0402010K0AAATAT
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 25mg/5ml oral liquid
0402010K0AAAFAF
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 3mg/5ml oral liquid
0402010K0AAAQAQ
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 4mg/5ml oral liquid
0402010K0AAAKAK
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 50mg/5ml oral liquid
0402010K0AAAHAH
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 6.25mg/5ml oral liquid
0402010K0AAADAD
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine maleate 2.5mg/5ml oral solution
0402010K0AAALAL
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine maleate 6mg/5ml oral solution
0402010K0AAAPAP
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.